10-Q Filing

ENZON PHARMACEUTICALS, INC. CIK: 727510 Q1 2013

Filing Information

Form Type	10-Q
Accession Number	`0001144204-13-027985`
Period End Date	20130331
Filing Date	20130510
Fiscal Year	2013
Fiscal Period	Q1
XBRL Instance	enzn-20130331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 56 Income Statement 51 Cash Flow Statement 46

Balance Sheet 56 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$77.35M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$46.21M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$121.74M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$104.32M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$77.57M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$119.39M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.95M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.90M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Total current assets	`AssetsCurrent`	$201.26M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$198.64M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.14M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.04M	USD	Point-in-time
Total assets	`Assets`	$199.78M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	43.72M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	43.67M	shares	Point-in-time
Total assets	`Assets`	$202.30M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	43.72M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	43.67M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$776.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$673.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$6.32M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$5.69M	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$115.85M	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$115.85M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$122.31M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$122.84M	USD	Point-in-time
Total liabilities	`Liabilities`	$122.31M	USD	Point-in-time
Total liabilities	`Liabilities`	$122.84M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock - $.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at March 31, 2013 and December 31, 2012	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock - $.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at March 31, 2013 and December 31, 2012	`PreferredStockValue`	-	USD	Point-in-time
Common stock - $.01 par value, authorized 170,000,000 shares;issued and outstanding 43,715,451 shares at March 31,2013 and 43,674,170 shares at December 31, 2012	`CommonStockValue`	$437.00K	USD	Point-in-time
Common stock - $.01 par value, authorized 170,000,000 shares;issued and outstanding 43,715,451 shares at March 31,2013 and 43,674,170 shares at December 31, 2012	`CommonStockValue`	$437.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$224.44M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$224.80M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$83.00K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$39.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-145.46M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-147.85M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$79.46M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$77.47M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$202.30M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$199.78M	USD	Point-in-time

Income Statement 51 line items

Line Item	Tag	Value	Unit	Period
Royalties	`RoyaltyRevenue`	$9.56M	USD	1 Quarter
Royalties	`RoyaltyRevenue`	$10.32M	USD	1 Quarter
Contract research and development	`ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned`	-	USD	1 Quarter
Contract research and development	`ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned`	$103.00K	USD	1 Quarter
Miscellaneous income	`OtherSalesRevenueNet`	$177.00K	USD	1 Quarter
Miscellaneous income	`OtherSalesRevenueNet`	$619.00K	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$10.60M	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$10.18M	USD	1 Quarter
Research and development - pipeline	`ResearchAndDevelopmentExpense`	$1.58M	USD	1 Quarter
Research and development - pipeline	`ResearchAndDevelopmentExpense`	$6.91M	USD	1 Quarter
Research and development - specialty and contracted services	`ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross`	$85.00K	USD	1 Quarter
Research and development - specialty and contracted services	`ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross`	-	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$3.67M	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$2.95M	USD	1 Quarter
Restructuring charges	`RestructuringCharges`	$-37.00K	USD	1 Quarter
Restructuring charges	`RestructuringCharges`	$2.50M	USD	1 Quarter
Restructuring charges	`RestructuringCharges`	$2.50M	USD	Annual
Total operating expenses	`OperatingExpenses`	$7.03M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$10.64M	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$-36.00K	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$3.15M	USD	1 Quarter
Investment income, net	`InvestmentIncomeNet`	$478.00K	USD	1 Quarter
Investment income, net	`InvestmentIncomeNet`	$427.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$1.27M	USD	1 Quarter
Interest expense	`InterestExpense`	$1.42M	USD	1 Quarter
Other, net	`OtherNonoperatingIncomeExpense`	$220.00K	USD	1 Quarter
Other, net	`OtherNonoperatingIncomeExpense`	$-96.00K	USD	1 Quarter
Total other (expense)	`NonOperatingIncomeExpenseIncludingInterestExpense`	$-1.03M	USD	1 Quarter
Total other (expense)	`NonOperatingIncomeExpenseIncludingInterestExpense`	$-627.00K	USD	1 Quarter
Income (loss) before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.07M	USD	1 Quarter
Income (loss) before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$2.52M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$133.00K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-1.07M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$2.39M	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.05	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.02	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.02	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.05	USD	1 Quarter
Weighted-average shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	48.29M	shares	1 Quarter
Weighted-average shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	43.69M	shares	1 Quarter
Weighted-average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	61.12M	shares	1 Quarter
Weighted-average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	48.29M	shares	1 Quarter
Unrealized holding gains arising during period	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$39.00K	USD	1 Quarter
Unrealized holding gains arising during period	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$537.00K	USD	1 Quarter
Reclassification adjustment for realized (gains) losses on sales included in net income (loss)	`OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax`	$35.00K	USD	1 Quarter
Reclassification adjustment for realized (gains) losses on sales included in net income (loss)	`OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax`	$-281.00K	USD	1 Quarter
Total other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-242.00K	USD	1 Quarter
Total other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$572.00K	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$2.15M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-499.00K	USD	1 Quarter

Cash Flow Statement 46 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$-1.07M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$2.39M	USD	1 Quarter
Depreciation	`DepreciationAndAmortization`	$1.30M	USD	1 Quarter
Depreciation	`DepreciationAndAmortization`	$80.00K	USD	1 Quarter
Amortization and write-off of debt issuance costs	`AmortizationOfFinancingCosts`	$116.00K	USD	1 Quarter
Amortization and write-off of debt issuance costs	`AmortizationOfFinancingCosts`	$147.00K	USD	1 Quarter
Stock-based compensation and employee purchase plan discount	`ShareBasedCompensation`	$-257.00K	USD	1 Quarter
Stock-based compensation and employee purchase plan discount	`ShareBasedCompensation`	$468.00K	USD	1 Quarter
(Gain) loss on sales of marketable securities	`MarketableSecuritiesGainLoss`	$-281.00K	USD	1 Quarter
(Gain) loss on sales of marketable securities	`MarketableSecuritiesGainLoss`	$35.00K	USD	1 Quarter
Losses on early retirement of notes payable	`GainsLossesOnExtinguishmentOfDebt`	$113.00K	USD	1 Quarter
Losses on early retirement of notes payable	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Amortization of purchase premium on marketable securities	`AmortizationOfPurchasePremiumOnMarketableSecurities`	$536.00K	USD	1 Quarter
Amortization of purchase premium on marketable securities	`AmortizationOfPurchasePremiumOnMarketableSecurities`	$752.00K	USD	1 Quarter
(Gain) loss on disposal of fixed assets	`GainLossOnDispositionOfAssets`	$-219.00K	USD	1 Quarter
(Gain) loss on disposal of fixed assets	`GainLossOnDispositionOfAssets`	-	USD	1 Quarter
Changes in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$-2.24M	USD	1 Quarter
Changes in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$388.00K	USD	1 Quarter
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-496.00K	USD	1 Quarter
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$2.75M	USD	1 Quarter
Proceeds from sales of fixed assets	`PaymentsToAcquirePropertyPlantAndEquipment`	$-235.00K	USD	1 Quarter
Proceeds from sales of fixed assets	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	1 Quarter
Proceeds from sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$41.53M	USD	1 Quarter
Proceeds from sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$40.99M	USD	1 Quarter
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$94.75M	USD	1 Quarter
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	-	USD	1 Quarter
Net cash provided by (used in ) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-53.77M	USD	1 Quarter
Net cash provided by (used in ) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$41.76M	USD	1 Quarter
Repurchases of notes payable	`ProceedsFromRepaymentsOfNotesPayable`	$-3.86M	USD	1 Quarter
Repurchases of notes payable	`ProceedsFromRepaymentsOfNotesPayable`	-	USD	1 Quarter
Withholding taxes - stock based compensation	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$106.00K	USD	1 Quarter
Withholding taxes - stock based compensation	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	-	USD	1 Quarter
Withdrawals/proceeds from employee stock purchase plan	`ProceedsFromStockPlans`	$-14.00K	USD	1 Quarter
Withdrawals/proceeds from employee stock purchase plan	`ProceedsFromStockPlans`	$15.00K	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-3.85M	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-120.00K	USD	1 Quarter
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$44.39M	USD	1 Quarter
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-58.11M	USD	1 Quarter
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$77.35M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$46.21M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$121.74M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$104.32M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$77.35M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$46.21M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$121.74M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$104.32M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.